NAS:IBB
iShares Biotechnology ETF | |
| $ 205.49 -1.84 ( -0.89%) 04:00 PM EST | |
PE Ratio:
23.04
PB Ratio:
5.05
Volume:
1.11M
Dividend Yield %:
0.2
| |
| Last Holding update 2026-08-25 | 239 Stocks (0 new) |
| Value $9.08 Bil | Turnover 4 % |
Registrant: iShares Biotechnology ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
7 /10
Profitability Rank
5 /10
GF Value Rank
5 /10
Growth Rank
8 /10
Momentum Rank
6 /10
iShares Biotechnology ETF Geographic Breakdown
iShares Biotechnology ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
iShares Biotechnology ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 206.57 | ||
| Day's Range ($) | 205.2001 - 207.85 | ||
| Day's Volume | 1,108,787 | ||
| 52-Week Range ($) | 138.79 - 217.12 | ||
| Beta | 0.719 | ||
| 3-Year Sharpe Ratio | 0.72 | ||
| 3-Year Sortino Ratio | 1.32 | ||
| Volatility | 19.42 | ||
| 14-Day RSI | 52.71 | ||
| 14-Day ATR ($) | 4.179684 | ||
| 20-Day SMA ($) | 208.957 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 10,408.07 | ||
| Shares Outstanding (Mil) | 50.65 | ||
| PE Ratio | 23.04 | ||
| PE Ratio (10y Range) | 12.7 - 74.16 | ||
| PE Ratio (10y Median) | 21.8 | ||
| PB Ratio | 5.05 | ||
| PB Ratio (10y Range) | 1.69 - 7.5 | ||
| PB Ratio (10y Median) | 4.79 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | 0.412 | ||
| Dividend Yield % | 0.2 | ||
| Dividend Yield % (10y Range) | 0.12 - 0.45 | ||
| Dividend Yield % (10y Median) | 0.26 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
IBB iShares Biotechnology ETF Fundamental Charts
Historical TTM Price-to-Earnings for IBB iShares Biotechnology ETF
Historical TTM Price-to-Earnings without NRI for IBB iShares Biotechnology ETF
Historical Price-to-Book Ratio for IBB iShares Biotechnology ETF
Historical Dividend Yields for IBB iShares Biotechnology ETF
iShares Biotechnology ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:IBB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IBB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares Biotechnology ETF Top Holdings of 2026-06-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | 1,478,300 | 734,316.0 | +9.18% | 8.090 | +0.68% | 0.580 | +16.90% | +14.95% | 132,083.6 | Biotechnology | |
AMGN | Amgen Inc | 1,964,435 | 711,361.2 | +13.34% | 7.840 | +0.92% | 0.360 | +14.22% | +21.99% | 211,533.1 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 4,921,526 | 621,785.6 | +8.99% | 6.850 | +0.56% | 0.400 | +16.82% | +20.12% | 180,599.5 | Drug Manufacturers | |
REGN | Regeneron Pharmaceuticals Inc | 715,060 | 445,868.5 | -5.69% | 4.910 | -0.41% | 0.690 | +31.23% | +5.04% | 83,151.6 | Biotechnology | |
ARGX | argenx SE | 368,177 | 341,583.6 | +7.69% | 3.760 | +0.27% | 0.590 | +13.38% | +19.19% | 62,626.1 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 942,174 | 283,622.6 | -3.82% | 3.120 | -0.15% | 0.700 | -13.33% | -35.12% | 34,522.8 | Biotechnology | |
NTRA | Natera Inc | 967,683 | 262,677.5 | -1.32% | 2.890 | -0.03% | 0.670 | +48.24% | +44.18% | 47,612.3 | Medical Diagnostics & Research | |
RVMD | Revolution Medicines Inc | 1,349,118 | 252,662.8 | +5.08% | 2.780 | +0.13% | 0.630 | +38.87% | +160.74% | 44,513.4 | Biotechnology | |
BIIB | Biogen Inc | 1,037,164 | 224,089.6 | -4.94% | 2.470 | -0.12% | 0.700 | +5.84% | +19.74% | 31,136.2 | Drug Manufacturers | |
ILMN | Illumina Inc | 1,069,358 | 188,025.2 | -3.43% | 2.070 | -0.06% | 0.710 | +28.10% | +56.30% | 30,955.0 | Medical Diagnostics & Research |
iShares Biotechnology ETF's Historical Top Holdings Breakdowns
iShares Biotechnology ETF's Top Stock Picks
View Full List
| Ticker |
|---|
AMGN |
VRTX |
GILD |
| ACLX Unlock Delisted |
| TERN Unlock Delisted |
REGN |
| FOLD Unlock Delisted |
| APLS Unlock Delisted |
ASND |
ARGX |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
AMGN | Amgen Inc | 2026-06-30 | Add Add | +0.92% | 323.85 ($342.47) 362.12 | $391.27 | 14.25% | Add 13.34% | 1,964,435 | 231,287 | |
VRTX | Vertex Pharmaceuticals Inc | 2026-06-30 | Add Add | +0.68% | 423.24 ($443.24) 499.65 | $521.12 | 17.57% | Add 9.18% | 1,478,300 | 124,267 | |
GILD | Gilead Sciences Inc | 2026-06-30 | Add Add | +0.56% | 121.48 ($131.88) 142.09 | $145.65 | 10.44% | Add 8.99% | 4,921,526 | 405,819 | |
| ACLX Unlock Delisted | Arcellx Inc | 2026-06-30 | Sold Out Sold Out | -0.48% | 114.72 ($114.93) 115.1 | $115.07 | 0.12% | Sold Out | 0 | -335,814 | |
| TERN Unlock Delisted | Terns Pharmaceuticals Inc | 2026-06-30 | Sold Out Sold Out | -0.46% | 52.56 ($52.79) 52.95 | $52.95 | 0.30% | Sold Out | 0 | -713,848 | |
REGN | Regeneron Pharmaceuticals Inc | 2026-06-30 | Reduce Reduce | -0.41% | 600.66 ($682.14) 777.25 | $807.65 | 18.40% | Reduce -5.69% | 715,060 | -43,172 | |
| FOLD Unlock Delisted | Amicus Therapeutics Inc | 2026-06-30 | Sold Out Sold Out | -0.41% | 14.44 ($14.46) 14.49 | $14.49 | 0.21% | Sold Out | 0 | -2,307,725 | |
| APLS Unlock Delisted | Apellis Pharmaceuticals Inc | 2026-06-30 | Sold Out Sold Out | -0.39% | 40.23 ($40.86) 41.12 | $41.03 | 0.42% | Sold Out | 0 | -778,245 | |
ASND | Ascendis Pharma AS | 2026-06-30 | Add Add | +0.29% | 205.81 ($232.73) 266.72 | $260.81 | 12.07% | Add 28.88% | 438,135 | 98,187 | |
ARGX | argenx SE | 2026-06-30 | Add Add | +0.27% | 730.25 ($823.44) 927.77 | $1,002.31 | 21.72% | Add 7.69% | 368,177 | 26,294 |
iShares Biotechnology ETF Total Holding History ($B)
iShares Biotechnology ETF's Asset Allocation
iShares Biotechnology ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
iShares Biotechnology ETF's Hypothetical Growth since 2026-06-30
iShares Biotechnology ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
iShares Biotechnology ETF's Holdings Heat Map
Size field: